GB0501156D0 - General cure to diseases idea 3 - Google Patents

General cure to diseases idea 3

Info

Publication number
GB0501156D0
GB0501156D0 GBGB0501156.4A GB0501156A GB0501156D0 GB 0501156 D0 GB0501156 D0 GB 0501156D0 GB 0501156 A GB0501156 A GB 0501156A GB 0501156 D0 GB0501156 D0 GB 0501156D0
Authority
GB
United Kingdom
Prior art keywords
idea
diseases
blood
general cure
cure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0501156.4A
Other versions
GB2422311A8 (en
GB2422311A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0501156A priority Critical patent/GB2422311A/en
Publication of GB0501156D0 publication Critical patent/GB0501156D0/en
Publication of GB2422311A publication Critical patent/GB2422311A/en
Publication of GB2422311A8 publication Critical patent/GB2422311A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method of treating a sample of blood from a diseased patient wherein said blood is subjected to acid or alkaline treatment. The blood is then returned to the patient to stimulate an immune response.
GB0501156A 2005-01-20 2005-01-20 Treatment of blood to cure disease Withdrawn GB2422311A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0501156A GB2422311A (en) 2005-01-20 2005-01-20 Treatment of blood to cure disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0501156A GB2422311A (en) 2005-01-20 2005-01-20 Treatment of blood to cure disease

Publications (3)

Publication Number Publication Date
GB0501156D0 true GB0501156D0 (en) 2005-03-02
GB2422311A GB2422311A (en) 2006-07-26
GB2422311A8 GB2422311A8 (en) 2006-08-18

Family

ID=34259377

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0501156A Withdrawn GB2422311A (en) 2005-01-20 2005-01-20 Treatment of blood to cure disease

Country Status (1)

Country Link
GB (1) GB2422311A (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1222600A (en) * 1958-01-20 1960-06-10 Celanese Corp Filamentous materials based on cellulose triacetate
EP0072843A1 (en) * 1981-02-18 1983-03-02 University Patents, Inc. Precipitation of proteins
ZW7583A1 (en) * 1982-04-07 1983-06-29 Baylor College Medicine Products and methods for treatment of cancer
US4663049A (en) * 1984-07-05 1987-05-05 University Of Utah Process for therapeutic dissociation of immune complexes and removal of antigens
US4678566A (en) * 1984-07-20 1987-07-07 Terumo Kabushiki Kaisha Apparatus for separating proteins from blood plasma
JPH02500022A (en) * 1986-08-01 1990-01-11 ルービンスタイン，アラン，アイ Novel blood processing method
WO2001080866A1 (en) * 2000-04-26 2001-11-01 Gauchet Jean Yves Immunostimulatory pharmaceutical composition and its use protocol

Also Published As

Publication number Publication date
GB2422311A8 (en) 2006-08-18
GB2422311A (en) 2006-07-26

Similar Documents

Publication Publication Date Title
ATE355852T1 (en) USE OF BOTULINUM TOXIN FOR THE TREATMENT OF HEART AND Circulatory Diseases
WO2009038720A3 (en) Method and apparatus for applying light therapy
ATE446102T1 (en) TREATMENT OF WEIGHT LOSS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE USING S. BOULARDII
ATE411399T1 (en) TREATING HUNTINGTON'S DISEASE WITH EPA
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
ATE524070T1 (en) METHOD FOR USING CELLS DERIVED FROM FAT TISSUE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
BRPI0415533A (en) therapy method
DE602005026724D1 (en) METHOD FOR THE USE OF FAT-FROZEN CELLS IN THE TREATMENT OF HEART CIRCUIT SLEEPING
DE502005010615D1 (en) MEDICINE FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE602006017071D1 (en) COMPOSITIONS AND METHODS OF TREATING HEART DISEASES
ATE499934T1 (en) USE OF (3.2.0) HETEROCYCLIC COMPOUNDS AND THEIR ANALOGUES FOR THE TREATMENT OF CANCER
EA201001691A1 (en) ANTIBODIES TO GRANULOCYTER-MACROPHAGAL COLONIUS STIMULATING FACTOR
NO20076121L (en) Treatments for cardiovascular disease
IL174525A0 (en) Medicamentously targeted local lipolysis
ATE460940T1 (en) IRON(III) COMPLEX COMPOUNDS FOR THE ORAL TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE
WO2006014159A3 (en) Methods of using regenerative cells in the treatment of musculoskeletal disorders
WO2008035344A3 (en) A device and method for deep brain stimulation as a new form of treating chronic depression
WO2007014943A3 (en) Therapy for neurological diseases
HK1175495A1 (en) New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
CY1111353T1 (en) USE OF KALALIDIS COMPOUNDS FOR PRODUCTION OF MEDICINE FOR TREATMENT OF PORCELAIN
TW200718783A (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
DE50100833D1 (en) USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AND / OR ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR PRODUCING A MEDICINE FOR TREATING CANCER DISEASES
GB0501156D0 (en) General cure to diseases idea 3
SG156658A1 (en) Treatment of diseases

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)
APTC Appeals to the court
APTC Appeals to the court

Free format text: APPEAL DISMISSED; APPEAL WAS DISMISSED.